February 25, 2022
Jansen’s Story
- By Suzanne and Brent Jones
- Posted in Patient & Family Stories
Edited by Kyle W. Davis, CGC and Marimac Moore In honor of Rare Disease Day 2022, we want to introduce...
February 25, 2022
Company Spotlight Series: Lucy Kaplun
- By Lucy Kaplun, Ph.D.
- Posted in Company Spotlight Series
As I reflect back, I don’t feel that this one decision determined my career necessarily. It was actually the exciting...
February 12, 2022
Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding
- By Variantyx
- Posted in General Company Updates
Funding Round is Led by New Era Capital Partners and Includes Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners,...
December 14, 2021
Variantyx Winter Holiday Hours of Operation
- By Variantyx, Inc
- Posted in General Company Updates
Valued Customers, We would like to update you on our winter holiday hours of operation: Our offices will be closed...
November 12, 2021
Variantyx and Robert-Bosch Hospital team up to improve personalized oncology treatment
- By STUTTGART
- Posted in General Company Updates
STUTTGART, Germany, Nov. 15, 2021 PRNewswire Robert Bosch Venture Capital GmbH, the corporate venture capital company of the Bosch Group, has...
August 31, 2021
ACMG secondary findings updated list for reporting of secondary findings, for medically actionable genes in clinical exome and genome sequencing
- By Variantyx, Inc
- Posted in Secondary & Incidental Findings
ACMG secondary findings updated list for reporting of secondary findings, for medically actionable genes in clinical exome and genome sequencing. ...
May 11, 2021
Variantyx Expands Into Prenatal, Cancer Testing
- By Variantyx
- Posted in General Company Updates
Genomeweb | May 11, 2021 Variantyx, a genetic testing company offering clinical whole-genome sequencing-based assays, is expanding its menu to...
March 15, 2021
Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disorders
- By Variantyx
- Posted in General Company Updates
March 15, 2021 Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding...
February 27, 2021
Whole-genome sequencing and health insurance
By Daryl Spinner, PhD, MBA In the realm of genetic testing, insurance payers have been reluctant to recognize that there...
February 8, 2021
Industry Voices – Whole-genome sequencing ultimately benefits payers
- By Daryl Spinner, PhD, MBA
- Posted in Article
When solving a problem, taking a step back and looking at the big picture is often a wise tactic. In...